Evoke Pharma Inc Earnings Per Share, Basic in USD/shares from Q2 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Evoke Pharma Inc quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2016 to Q3 2025.
  • Evoke Pharma Inc Earnings Per Share, Basic for the quarter ending September 30, 2025 was -0.45 USD/shares, a 52.1% increase year-over-year.
  • Evoke Pharma Inc Earnings Per Share, Basic for the twelve months ending September 30, 2025 was 0 USD/shares, a 97.7% increase year-over-year.
  • Evoke Pharma Inc annual Earnings Per Share, Basic for 2024 was -2.81 USD/shares, a 90% increase from 2023.
  • Evoke Pharma Inc annual Earnings Per Share, Basic for 2023 was -28 USD/shares, a 968% decline from 2022.
  • Evoke Pharma Inc annual Earnings Per Share, Basic for 2022 was -2.62 USD/shares, a 17.6% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Evoke Pharma Inc Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $0 $0 +$0.49 +52.1% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-13
Q2 2025 $0 -$1 +$0.31 +33.3% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 -$1 -$1 +$1.58 +75.6% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 -$2 $1.15 +$15.70 Oct 1, 2024 Dec 31, 2024 10-K 2025-03-13
Q3 2024 -$18 -$1 +$5.14 +84.5% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-13
Q2 2024 -$23 -$1 +$5.78 +86.1% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 -$29 -$2 -$1 -212% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 -$27 -$15 -$14 -2745% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-13
Q3 2023 -$13 -$6 -$5 -913% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$8 -$7 -$6 -845% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$2 -$1 +$0.13 +16.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$2 -$1 Oct 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
Q3 2022 -$1 +$0.13 +17.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$1 +$0.14 +16.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$1 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 -$1 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$1 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q3 2018 $0 +$0.25 +73.5% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $0 $0 -27.3% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-09
Q4 2017 $0 $0 Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 $0 $0 -17.2% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-06
Q2 2017 $0 +$0.30 +73.2% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-06
Q1 2017 $0 Jan 1, 2017 Mar 31, 2017 10-K 2019-03-06
Q3 2016 $0 Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $0 Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14

Evoke Pharma Inc Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$3 +$25.20 +90% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-13
2023 -$28 -$25 -968% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-13
2022 -$3 +$0.56 +17.6% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
2021 -$3 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-21
2018 $0 +$0.36 +43.9% Jan 1, 2018 Dec 31, 2018 10-K 2019-03-06
2017 -$1 +$0.33 +28.7% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 -$1 Jan 1, 2016 Dec 31, 2016 10-K 2018-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.